Reimbursement News
Reimbursement news and insurance coverage updates.
EntroGen Colorectal Cancer RAS Mutation Detection Test Nabs CMS Coverage
The real-time PCR-based companion diagnostic test identifies patients eligible for treatment with Amgen's Vectibix (panitumumab).
Interpace Diagnostics to Cease PancraGen Testing After Losing CMS Reimbursement
The fate of its pancreatic cancer test had been in limbo for years, but with a newly active LCD from Medicare contractor Novitas, the firm has had to close the book on the assay.
NICE Backs Novartis' Kisqali, Aromatase Inhibitor for Certain Breast Cancer Patients
The draft guidance makes the regimen available to HR-positive early-stage breast cancer patients with lymph node-positive disease through the Cancer Drugs Fund.
Health Insurance Coverage for Biomarker Testing Becomes Law in New Jersey
State-regulated insurers in New Jersey must now cover biomarker testing for diagnosis, treatment, and monitoring.
NICE Recommends Pharming Group's Joenja for Activated Phosphoinositide 3-Kinase Delta Syndrome
Joenja will be the first drug specifically for APDS to be reimbursed within the NHS and is available immediately in England and soon will be in Wales.